74°
Feels Like: 74°
85°
65°
89°
By Toni Clarke (Reuters) - U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceutic...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) -Though long-term hormone replacement therapy has serious health risks, going off the med...
Read More »(Reuters) - Generic drugmaker Actavis Inc bought the global rights to Canadian firm Valeant Pharmaceuticals International Inc's anti...
Read More »By Mette Fraende and Shida Chayesteh COPENHAGEN (Reuters) - Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hop...
Read More »
By Padraic Halpin DUBLIN (Reuters) - Irish government ministers agreed draft legislation on Tuesday to allow for limited access to a...
Read More »WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday said it would allow the Plan B One-Step contraceptive to be ...
Read More »
By Daniel Trotta (Reuters) - A trade group representing makers of artificial limbs on Tuesday promised to provide prosthetics free o...
Read More »By Bill Berkrot (Reuters) - Vertex Pharmaceuticals Inc on Tuesday increased by $20 million the 2013 forecast for sales of its cystic...
Read More »(Reuters) - Questcor Pharmaceuticals Inc's first-quarter profit lagged analysts' expectations as sales of its Acthar drug fell due t...
Read More »By Jessica Wohl (Reuters) - CVS Caremark Corp is set to provide pharmacy benefit and other services for 1.1 million CareFirst BlueCr...
Read More »
